0001837265-20-000002.txt : 20201222
0001837265-20-000002.hdr.sgml : 20201222
20201222170414
ACCESSION NUMBER: 0001837265-20-000002
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201222
DATE AS OF CHANGE: 20201222
EFFECTIVENESS DATE: 20201222
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Faze Medicines, Inc.
CENTRAL INDEX KEY: 0001837265
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-384105
FILM NUMBER: 201408877
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 440
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6174606634
MAIL ADDRESS:
STREET 1: 215 FIRST STREET, SUITE 440
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
D
1
primary_doc.xml
X0708
D
LIVE
0001837265
Faze Medicines, Inc.
215 First Street, Suite 440
Cambridge
MA
MASSACHUSETTS
02142
617-460-6634
DELAWARE
Small Molecule RNA Co., Inc.
None
Corporation
true
2018
Cary
Pfeffer
215 First Street, Suite 440
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Director
Ed
Freedman
215 First Street, Suite 440
Cambridge
MA
MASSACHUSETTS
02142
Executive Officer
Director
Robert
Tepper
215 First Street, Suite 440
Cambridge
MA
MASSACHUSETTS
02142
Director
Charles
Homcy
215 First Street, Suite 440
Cambridge
MA
MASSACHUSETTS
02142
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-12-08
false
true
false
0
81000000
30375000
50625000
false
9
0
0
0
false
Faze Medicines, Inc.
/s/Cary Pfeffer
Cary Pfeffer
President
2020-12-22